LOGIN  |  REGISTER
Viking Therapeutics
Viking Therapeutics

Becton Dickinson Named a Best Employer for Excellence in Employee Well-Being

April 09, 2024 | Last Trade: US$225.15 2.02 -0.89

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives.

BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of employees in multiple countries and its commitment to equity, with a set of standard benefits offerings.

"Our purpose at BD is to advance the world of health, and we know that starts with prioritizing the health and well-being of our 70,000 global employees," said Kristi Payne, senior vice president of Global Total Rewards for BD. "Our integrated approach focuses on physical, emotional, financial and social well-being, and empowers our people to thrive—personally and professionally."

Applications were assessed based on their approaches to leadership, culture and well-being strategy; holistic well-being, including mental health, financial well-being, social connectedness, job satisfaction, flexibility and time away; engagement and the employee experience; health equity and social determinants; and metrics and evaluation.

This award is the latest accolade for BD employee well-being efforts. Also this year, BD was awarded by Cigna Healthcare with the Silver level "Healthy Workforce Designation," which recognizes companies for improving the health and well-being of U.S. associates through workplace wellness programs. Additionally, the American Heart Association awarded BD a Gold level recognition for its commitments to employee health and well-being as measured in the Association's 2023 Well-being Works Better Scorecard.

These recognitions reflect the company's efforts to achieve its 2030+ goals for promoting a healthy workforce and communities. These goals encompass maintaining a healthy and thriving workforce that cultivates the company's culture of inclusion, safety and well-being, and also contributes to community and company health. To learn more about BD's well-being programs, visit: https://jobs.bd.com/Our-CommitmentToYou.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Contacts:

Media:

Investors:

Troy Kirkpatrick

Adam Reiffe

VP, Public Relations

Sr. Director, Investor Relations

858.617.2361

201.847.6927 

This email address is being protected from spambots. You need JavaScript enabled to view it.        

This email address is being protected from spambots. You need JavaScript enabled to view it.     

Terns Pharmaceuticals

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB